Skip to main content

Amyloidogenic Immunoglobulin Chain and Non-amyloidogenic Immunoglobulin Chain Diseases

  • Reference work entry
  • First Online:
Tumors and Tumor-Like Lesions of the Hepatobiliary Tract
  • 85 Accesses

Abstract

B-cell non-Hodgkin’s lymphomas (NHL) can be associated with amyloidogenic immunoglobulin chain and non-amyloidogenic immunoglobulin chain disease. In both groups of disorders, the hepatobiliary tract can be involved in form of various patterns. Hepatic amyloidosis caused by NHL is termed amyloid light-chain or AL amyloidosis (primary amyloidosis) and develops in the setting of various B-cell neoplasms, most commonly with plasmacytoma. This form of amyloidosis induces an enlarged liver with increased transparency and elevated consistency. The predominant histological localization of amyloid is perisinusoidal and in portal tracts, associated with marked atrophy of hepatocyte plates. In a minority of cases of AL amyloidosis, tumor-like amyloid masses can develop (amyloidoma or amyloid tumor). This tumefactive hepatic amyloidosis is a very rare disorder. Amyloidosis can rarely involve intrahepatic and extrahepatic bile ducts. Among non-amyloidogenic immunoglobulin chain diseases, light-chain deposit disease can involve the liver. The liver is in fact the most frequent extrarenal localization of this disorder and is characterized by the deposition of granular or ribbonlike non-congophilic material along sinusoids.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 1,599.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 2,499.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Agaram N, Shia J, Klimstra DS, Lau N, Lin O, Erlandson RA, Filippa DA, Godwin TA (2005) Globular hepatic amyloid: a diagnostic peculiarity that bears clinical significance. Hum Pathol 36:845–849

    Article  PubMed  Google Scholar 

  • Bedossa P, Fabre M, Paraf F, Martin E, Lemaigre G (1988) Light chain deposition disease with liver dysfunction. Hum Pathol 19:1008–1014

    Article  CAS  PubMed  Google Scholar 

  • Berrios M, Armas-Merino R, Franco C, Parrochia E, Wolff C (2003) Acute liver failure in patient with liver amyloidosis associated to multiple myeloma (in Spanish). Rev Med Chil 131:1301–1303

    Article  PubMed  Google Scholar 

  • Buck FS, Koss MN (1991) Hepatic amyloidosis: morphologic differences between systemic AL and AA types. Hum Pathol 22:904–907

    Article  CAS  PubMed  Google Scholar 

  • Buxbaum J, Gallo G (1999) Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light-and heavy-chain deposition diseases. Hematol Oncol Clin N Am 13:1235–1248

    Article  CAS  Google Scholar 

  • Buxbaum JN, Chuba JV, Hellman GC, Solomon A, Gallo GR (1990) Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition disease and their relation to light chain amyloidosis. Ann Intern Med 112:455–464

    Article  CAS  PubMed  Google Scholar 

  • Case records of the Massachusetts General Hospital (case 1 – 1981) (1981) N Engl J Med 304:33

    Google Scholar 

  • Casiraghi MA, De Paoli A, Assi A, Palladini G, Lavazza MT, Beretta A, Gualdoni G, Beretta R (2000) Hepatic amyloidosis with light chain deposition disease. A rare association. Dig Liver Dis 32:795–798

    Article  CAS  PubMed  Google Scholar 

  • Chopra S, Rubinow A, Koff RS, Cohen AS (1984) Hepatic amyloidosis. A histopathologic analysis of primary (AL) and secondary (AA) forms. Am J Pathol 115:186–193

    CAS  PubMed  PubMed Central  Google Scholar 

  • Cohen AS, Calkins E (1959) Electron microscopic observations on a fibrous component in amyloid of diverse origins. Nature 183:1202–1203

    Article  CAS  PubMed  Google Scholar 

  • Cohen AD, Zhou P, Xiao Q, Fleisher M, Kalakonda N, Akhurst T, Chitale DA, Moscowitz C et al (2004) Systemic AL amyloidosis due to non-Hodgkin’s lymphoma: an unusual clinicopathologic association. Br J Haematol 124:309–314

    Article  CAS  PubMed  Google Scholar 

  • Copeland JN, Kouides PA, Grieff M, Nadasdy T (2003) Metachronous development of nonamyloidogenic l light chain deposition disease and IgG heavy chain amyloidosis in the same patient. Am J Surg Pathol 27:1477–1482

    Article  PubMed  Google Scholar 

  • Cosme A, Horcajada JP, Vidaur F, Ojeda E, Torrado J, Areans JI (1995) Systemic AA amyloidosis induced by oral contraceptive-associated hepatocellular adenoma: a 13-year follow up. Liver 15:164–167

    Article  CAS  PubMed  Google Scholar 

  • Croitoru AG, Hytiroglou P, Schwartz ME, Saxena R (2006) Liver transplantation for liver rupture due to light chain deposition disease: a case report. Semin Liver Dis 26:298–303

    Article  PubMed  Google Scholar 

  • Cross TJ, Wendon JA, Quaglia A, Salisbury JR, Heneghan MA, Harrison PM (2006) Myeloma associated amyloidosis presenting as subacute liver failure. Postgrad Med J 82:e13

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Delgado MA, Liu JY, Meleg-Smith S (1999) Systemic amyloidosis associated with hepatocellular carcinoma. Case report and literature review. J La State Med Soc 151:474–478

    CAS  PubMed  Google Scholar 

  • Dickson JR, Harth M, Bell DA, Komar R, Chodirker WB (1989) Gamma heavy chain disease and rheumatoid arthritis. Semin Arthritis Rheum 18:247–251

    Article  CAS  PubMed  Google Scholar 

  • Divry P, Florkin M (1927) Sur les propriétés optiques de l’amyloide. CR Soc Biol (Paris) 97:1808–1810

    Google Scholar 

  • Dohmen K, Nagano M, Iwakiri R, Yamano Y, Kikuchi Y, Mizoguchi M, Iwata Y, Mori Y, Ishibashi H (1991) A case of prominent hepatic cholestasis developing to hepatic failure in lambda-AL amyloidosis. Gastroenterol Jpn 26:376–381

    CAS  PubMed  Google Scholar 

  • Droz D, Noel LH, Carnot F, Degos F, Ganeval D, Grunfeld JP (1984) Liver involvement in nonamyloid light chain deposit disease. Lab Invest 50:683–689

    CAS  PubMed  Google Scholar 

  • Econimo L, Jeannin G, Biasi L, Mazzola G, Mendeni M, Presteni K, Gregorini G (2011) Liver involvement with rapidly progressive course in light chain (AL) amyloidosis: distinguishing features at presentation. Experience of a single center. Amyloid 18(suppl a):109–111

    Article  PubMed  Google Scholar 

  • Eulitz M, Weiss DT, Solomon A (1990) Immunoglobulin heavy-chain associated amyloidosis. Proc Natl Acad Sci U S A 87:6542–6546

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Faa G, Van Eyken P, De Vos R, Fevery J, Van Damme B, De Groote J, Desmet VJ (1991) Light chain deposition disease of the liver associated with AL-type amyloidosis and severe cholestasis. J Hepatol 12:75–82

    Article  CAS  PubMed  Google Scholar 

  • Ferreira S, Baldaia C, Fatela N, Ramalho F, Costa MA, Brito D, Esteves G, Monteiro E (2008) Severe intrahepatic cholestasis, erythrocytosis and hypoglycemia: unusual presenting features of systemic AL amyloidosis. Scand J Gastroenterol 43:375–379

    Article  CAS  PubMed  Google Scholar 

  • Fievet P, Sevestre H, Boudjelal M, Noel LH, Kemeny F, Franco D, Delamarre J, Capron JP (1990) Systemic AA amyloidosis induced by liver cell adenoma. Gut 31:361–363

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Frangione B, Franklin EC (1973) Heavy chain diseases: clinical features and molecular significance of the disordered immunoglobulin structure. Semin Hematol 10:54–64

    Google Scholar 

  • French SW, Schloss GT, Stillman AE (1981) Unusual amyloid bodies in human liver. Am J Clin Pathol 75:400–402

    Article  CAS  PubMed  Google Scholar 

  • Ganeval D, Noel LH, Droz D, Leibowitch J (1981) Systemic lambda light- chain deposition in a patient with myeloma. Br Med J 282:681–683

    Article  CAS  Google Scholar 

  • Ganeval D, Mignon F, Preud’homme JL, Noel LH, Morel-Maroger L, Droz D, Brouet JC et al (1982) Visceral deposition of monoclonal light chains and immunoglobulins: a study of renal and immunopathologic abnormalities. Adv Nephrol 11:25–63

    CAS  Google Scholar 

  • Gertz MA, Kyle RA (1988) hepatic amyloidosis (primary [AL], immunoglobulin light chain): the natural history in 80 patients. Am J Med 85:73–80

    Article  CAS  PubMed  Google Scholar 

  • Gertz MA, Kyle RA, Noel P (1993) Primary systemic amyloidosis: a rare complication of immunoglobulin M monoclonal gammopathies and Waldenström’s macroglobulinemia. J Clin Oncol 11:914–920

    CAS  PubMed  Google Scholar 

  • Gioeva Z, Kieninger B, Röcken C (2009) Amyloidosis in liver biopsies (in German). Pathologe 30:240–245

    Article  CAS  PubMed  Google Scholar 

  • Girelli C, Giovanni L, Rocca F (1998) Light chain deposition disease of the liver. Eur J Gastroenterol Hepatol 10:429–430

    Article  CAS  PubMed  Google Scholar 

  • Glenner GG (1980) Amyloid deposits and amyloidosis. The betafibrilloses (first of two parts). N Engl J Med 302:1283–1292

    Article  CAS  PubMed  Google Scholar 

  • Gono T, Yazaki M, Fushimi T, Suzuki T, Uehara T, Sano K, Kametani F, Ito N, Matsushita M et al (2006) AH amyloidosis associated with lymphoplasmacytic lymphoma secreting a monoclonal gamma heavy chain carrying an unusual truncated D segment. Am J Kidney Dis 47:908–914

    Article  PubMed  Google Scholar 

  • Hall CL, Peat DS (2001) The interesting case light chain deposit disease: a frequent cause of diagnostic difficulty. Nephrol Dial Transplant 16:1939–1941

    Google Scholar 

  • Harrison RF, Hawkins PN, Roche WR, MacMahon RF, Hubscher SG, Buckels JA (1996) ‘Fragile’ liver and massive hepatic hemorrhage due to hereditary amyloidosis. Gut 38:151–152

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hemmer PR, Topazian MD, Gertz MA, Abraham SC (2007) Globular amyloid deposits isolated to the small bowel: a rare association with AL amyloidosis. Am J Surg Pathol 31:141–145

    Article  PubMed  Google Scholar 

  • Hoffman-guilaine C, Nochy D, Tricottet V, Mallet L, Bariety J, Camilleri JP (1984) La maladie des dépots de chaines légères: une entité anatomopathologique. Ann Pathol 4:105–113

    Google Scholar 

  • Hoffman MS, Stein BE, Davidian MM, Rosenthal WS (1988) Hepatic amyloidosis presenting as severe intrahepatic cholestasis: a case report and review of the literature. Am J Gastroenterol 83:783–785

    CAS  PubMed  Google Scholar 

  • Husby G (1983) Immunoglobulin-related (AL) amyloidosis. Clin Exp Rheumatol 1:353–358

    CAS  PubMed  Google Scholar 

  • Hydes TJ, Aspinall RJ (2012) Subacute liver failure secondary to amyloid light-chain amyloidosis. Gastroenterol Hepatol 8:205–208

    Google Scholar 

  • Iwamura S, Enzan H, Saibara T, Onishi S, Yamamoto Y (1995) Hepatic sinusoidal endothelial cells can store and metabolize serum immunoglobulin. Hepatology 22:1456–1461

    Article  CAS  PubMed  Google Scholar 

  • Iwata T, Hoshii Y, Kawano H, Gondo T, Takahashi M, Ishihara T, Yokota T, Ueta J, Uchino F (1995) Hepatic amyloidosis in Japan: histological and morphometric analysis based on amyloid proteins. Hum Pathol 26:1148–1153

    Article  CAS  PubMed  Google Scholar 

  • Jimenez-Zepeda VH (2012) Light chain deposition disease: novel biological insights and treatment advances. Int J Lab Hematol 34:347–355

    Article  CAS  PubMed  Google Scholar 

  • Kambham N, Markowitz GS, Appel GB, Kleiner MJ, Aucouturier P, D’Agati VD (1999) Heavy chain deposition disease: the disease spectrum. Am J Kidney Dis 33:954–962

    Article  CAS  PubMed  Google Scholar 

  • Kanel GC, Uchida T, Peters RL (1981) Globular hepatic amyloid – an unusual morphologic presentation. Hepatology 1:647–652

    Article  CAS  PubMed  Google Scholar 

  • Katz A, Zent R, Bargman JM (1994) IgG heavy-chain deposition disease. Mod Pathol 7:874–878

    CAS  PubMed  Google Scholar 

  • Kebbel A, Röcken C (2006) Immunohistochemical classification of amyloid in surgical pathology revisited. Am J Surg Pathol 30:673–683

    Article  PubMed  Google Scholar 

  • Kijner CH, Yousem SA (1988) Systemic light chain deposition disease presenting as multiple pulmonary nodules: a case report an review of the literature. Am J Surg Pathol 12:405–413

    Article  CAS  PubMed  Google Scholar 

  • Kirkpatrick CJ, Curry A, Galle J, Melzner I (1986) Systemic kappa light chain deposition and amyloidosis in multiple myeloma: novel morphological observations. Histopathology 10:1065–1076

    Article  CAS  PubMed  Google Scholar 

  • Kiyama M, Hoshii Y, Cui D, Kawano H, Kanda T, Ishihara T (2007) Immunohistochemical and immunochemical study of amyloid in liver affected by systemic Alambda amyloidosis with antibodies against three different regions of immunoglobulin lambda light chain. Pathol Int 57:343–350

    Article  CAS  PubMed  Google Scholar 

  • Klinkenberg N, Reis HE, Rakow L (1991) Liver involvement as leading symptom of a kappa light-chain deposit disease (in German). Med Klin (Munich) 86:394–398

    CAS  Google Scholar 

  • Konikoff F, Mor C, Stern S, Shaklai M, Halevy J, Theodor E (1987) Cholestasis and liver failure with lambda-AL amyloidosis. Gut 28:903–906

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kuçi H, Ebert MP, Röcken C (2007) Anti-lambda-light chain-peptide antibodies are suitable for the immunohistochemical classification of AL amyloid. Histol Histopathol 22:379–387

    PubMed  Google Scholar 

  • Kumar PN, Sandhya V, Venkatakrishnan L, Krishnaveni J, Mohanakrishnan A, Nirmala V (2012) Light chain deposition disease presenting as cholestatic jaundice: a case report. Oman Med J 27:56–59

    Article  PubMed  PubMed Central  Google Scholar 

  • Kwon AH, Tsuji K, Yamada H, Okazaki K, Sakaida N (2007) Amyloidosis of the gallbladder mimicking gallbladder cancer. J Gastroenterol 42:261–264

    Article  PubMed  Google Scholar 

  • Kwon JH, Jeong SH, Kim JW, Bang SM, Kim H, Kim YH, Song SH (2011) Case report: a case of light chain deposition disease involving liver and stomach with chronic hepatitis C virus infection and hepatocellular carcinoma. J Med Virol 83:810–814

    Article  PubMed  Google Scholar 

  • Kyle RA (2001) Historical review. Amyloidosis: a convoluted story. Br J Haematol 114:529–538

    Article  CAS  PubMed  Google Scholar 

  • Le Verger JC, Toulet R, Deugnier Y, Ramie MP (1985) Anomalies biologiques hépatiques au cours d’une maladie de chaines légères. Gastroenterol Clin Biol 9:184–185

    PubMed  Google Scholar 

  • Levitan N, Rubinow A, Bromer RH, Conlon CL, Doos WG, Hong WK (1985) Transformation of lymphoma to amyloidoma following radiation therapy. Hum Pathol 16:1072–1074

    Article  CAS  PubMed  Google Scholar 

  • Linardaki G, Drivas G, Archimandritis A (1997) AL-type amyloidosis presenting with rapidly deteriorating liver involvement. J Clin Gastroenterol 24:297–298

    Article  CAS  PubMed  Google Scholar 

  • Linder J, Croker BP, Vollmer RT, Shelburne J (1983) Systemic kappa light-chain deposition. An ultrastructural and immunohistochemical study. Am J Surg Pathol 7:85–93

    Article  CAS  PubMed  Google Scholar 

  • Looi LM, Sumithran E (1988) Morphologic differences in the pattern of liver infiltration between systemic AL and AA amyloidosis. Hum Pathol 19:732–735

    Article  CAS  PubMed  Google Scholar 

  • Lovat LB, Persey MR, Madhoo S, Pepys MB, Hawkins PN (1998) The liver in systemic amyloidosis: insights from 1231 serum amyloid P component scintigraphy in 484 patients. Gut 42:727–734

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Macias Robles MD, Navia-Osorio Garcia-Braga JM, Menendez Caro JL, Velasco Alonso J, Lopez Lagunas I (1994) Jaundice secondary to intrahepatic deposit of light chains as a presenting form of multiple myeloma (in Spanish). An Med Interna 11:74–76

    CAS  PubMed  Google Scholar 

  • Mai HL, Sheikh-Hamad D, Herrera GA, Gu X, Truong LD (2003) Immunoglobulin heavy chain can be amyloidogenic: morphologic characterization including immunoelectron microscopy. Am J Surg Pathol 27:541–545

    Article  PubMed  Google Scholar 

  • Mainenti PP, Petrelli G, Lamanda R, Amalfi G, Castiglione F (1997) Primary systemic amyloidosis with giant hepatomegaly and a swiftly progressive course. J Clin Gastroenterol 24:173–175

    Article  CAS  PubMed  Google Scholar 

  • Makhlouf HR, Goodman ZD (2007) Globular hepatic amyloid: an early stage in the pathway of amyloid formation: a study of 20 new cases. Am J Surg Pathol 31:1615–1621

    Article  PubMed  Google Scholar 

  • Maniatis A (1998) Pathophysiology of paraprotein production. Ren Fail 20:821–828

    Article  CAS  PubMed  Google Scholar 

  • Masai R, Wakui H, Togashi M, Maki N, Ohtani H, Komatsuda A, Sawada K (2009) Clinicopathological features and prognosis in immunoglobulin light and heavy chain deposition disease. Clin Nephrol 71:9–20

    Article  CAS  PubMed  Google Scholar 

  • Melin JP, Lecrique T, Wynckel A, Wong T, Noel LH, Belghiti J, Chanard J (1993) Remission of nephrotic syndrome related to AA amyloidosis after hepatic adenomectomy. Nephron 64:157–158

    Article  CAS  PubMed  Google Scholar 

  • Mena-Duran A, Muñoz VE, Pareja LG, Sanchis CJ (2012) Liver failure caused by light chain deposition disease associated with multiple myeloma. Intern Med 51:773–776

    Article  PubMed  Google Scholar 

  • Merlini G, Bellotti V (2003) Molecular mechanisms of amyloidosis. N Engl J Med 349:583–596

    Article  CAS  PubMed  Google Scholar 

  • Michopoulos S, Petraki K, Petraki C, Dimopulos MA (2002) Light chain deposition disease of the liver without renal involvement in a patient with multiple myeloma related to liver failure and rapid fatal outcome. Dig Dis Sci 47:730–734

    Article  PubMed  Google Scholar 

  • Mignon F, Morel-Maroger L, Cerf M, Preud’homme JL, Richet G (1980) Hepatic and renal deposits of kappa light chains revealing a dysglobulinemia (in French). Nephrologie 1:167–170

    CAS  PubMed  Google Scholar 

  • Mohr A, Miehlke S, Klauck S, Röcken C, Malfertheimer P (1999) hepatomegaly and cholestasis as primary clinical manifestations of an AL-kappa amyloidosis. Eur J Gastroenterol Hepatol 11:921–925

    Article  CAS  PubMed  Google Scholar 

  • Naito KS, Ichiyama T, Kawakami S, Kadoya M, Tabata T, Matsuda M, Ikeda S (2008) AL amyloidosis with spontaneous hepatic rupture: successful treatment by transcatheter hepatic artery embolization. Amyloid 15:137–139

    Article  PubMed  Google Scholar 

  • Nath SV, Peiris M, Bishton MJ, Maxwell E, Prince HM (2010) Light chain deposition disease presenting as massive hepatomegaly. Pathology 42:307–310

    Article  PubMed  Google Scholar 

  • Oe Y, Nakaya I, Yahata M, Sakuma T, Sato H, Soma J (2010) A case of g1-heavy chain deposition disease successfully treated with melphalan and prednisolone therapy. Intern Med 49:1411–1415

    Article  CAS  PubMed  Google Scholar 

  • Okabe M, Choi GH, Kudo M, Nakaya H, Kishimoto A, Suzuki H, Miyagishima T (1998) Hepatic failure due to myeloma-associated amyloidosis. J Gastroenterol 33:926–927

    Article  CAS  PubMed  Google Scholar 

  • Okura T, Miyoshi K, Nagao T, Jotoku M, Enomoto D, Irita J, Kurata M, Higaki J (2009) Light chain deposition disease developing 15 years following the diagnosis of monoclonal gammopathy of undetermined significance. Intern Med 48:101–104

    Article  PubMed  Google Scholar 

  • Park MA, Mueller PS, Kyle RA, Larson DR, Plevak MF, Gertz MA (2003) Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients. Medicine (Baltimore) 82:291–298

    Article  Google Scholar 

  • Paudice N, Farsetti S, Caroti L, Ciuti G, Tempestini A, Perfetto F, Bergesio F (2011) Severe recurrent intrahepatic cholestasis in systemic AL amyloidosis without evident liver involvement. Unexplained hepatic toxicity or a case of misdiagnosed liver amyloidosis? Amyloid 18(suppl 1):142–144

    Article  PubMed  Google Scholar 

  • Pelletier G, Fabre M, Attali P, Ladouch-Badre A, Ink O, Martin E, Etienne JP (1988) Light chain deposition disease presenting with hepatomegaly: an association with amyloid-like fibrils. Postgrad Med J 64:804–808

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Piard F, Yaziji N, Jarry O, Assem M, Martin L, Bernard A, Jacquot JP, Justrabo E (1998) Solitary plasmacytoma of the lung with light chain extracellular deposits: a case report and review of the literature. Histopathology 32:356–361

    Article  CAS  PubMed  Google Scholar 

  • Pilgaard J, Fenger C, Schaffalitzky de Muckadell OB (1993) Globular amyloid deposits in the liver. Histopathology 23:479–480

    Article  CAS  PubMed  Google Scholar 

  • Pinney JH, Hawkins PN (2012) Amyloidosis. Ann Clin Biochem 49:229–241

    Article  CAS  PubMed  Google Scholar 

  • Pozzi C, Locatelli F (2002) Kidney and liver involvement in monoclonal light chain disorders. Semin Nephrol 22:319–330

    CAS  PubMed  Google Scholar 

  • Pozzi C, Fogazzi GB, Banfi G, Strom EH, Ponticelli C, Locatelli F (1995) Renal disease and patient survival in light chain deposit disease. Clin Nephrol 43:281–287

    CAS  PubMed  Google Scholar 

  • Preud’homme JL, Morel-Maroger L, Brouet JC, Cerf M, Mignon F, Guglielmi P, Seligmann M (1980) Synthesis of abnormal immunoglobulins in lymphoplasmacytic disorders with visceral light chain deposition. Am J Med 69:703–710

    Article  PubMed  Google Scholar 

  • Ramirez-Alvarado M (2012) Amyloid formation in light chain amyloidosis. Curr Top Med Chem 12:2523–2533

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Randall RE, Williamson WC, Mullinax F, Tung MY, Still WJS (1976) Manifestations of systemic light chain deposition. Am J Med 60:293–299

    Google Scholar 

  • Remy AJ, Perney P, Bourat L, Ramos J, Marty M, Cabaniols H, Durand L, Quenet F, Blanc F (1995) Amyloidosis of the gallbladder. An unusual localization (in French). Gastroenterol Clin Biol 19:215–217

    CAS  PubMed  Google Scholar 

  • Reuben A (2004) The legend of the lardaceous liver. Hepatology 40:763–766

    Article  PubMed  Google Scholar 

  • Ronco P, Plaisier E, Aucouturier P (2011) Monoclonal immunoglobulin light and heavy chain deposition diseases: molecular models of common renal diseases. Contrib Nephrol 169:221–231

    Article  CAS  PubMed  Google Scholar 

  • Rosen DJ, Stavropoulos C, Travis WD, Ashton RC, Bhora FY, Connery CP (2008) Transdiaphragmatic amyloidoma. Ann Thorac Surg 86:310–312

    Article  PubMed  Google Scholar 

  • Rostagno A, Frizzera G, Ylagan L, Kumar A, Ghiso J, Gallo G (2002) Tumoral non-amyloidotic monoclonal immunoglobulin light chain deposits (‘aggregoma’): presenting feature of B-cell dyscrasia in three cases with immunohistochemical and biochemical analyses. Br J Haematol 119:62–69

    Article  CAS  PubMed  Google Scholar 

  • Rubinow A, Koff RS, Cohen AS (1978) Severe intrahepatic cholestasis in primary amyloidosis: a report of four cases and a review of the literature. Am J Med 64:937–946

    Article  CAS  PubMed  Google Scholar 

  • Ryan RJ, Sloan JM, Collins AB, Mansouri J, Raje NS, Zukerberg LR, Ferry JA (2012) Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with amyloid deposition: a clinicopathologic case series. Am J Clin Pathol 137:51–64

    Article  PubMed  Google Scholar 

  • Samanez C, Domingo A, Cibeira MT, Miquel R, Soler M, Bladé J (2006) Development of rapidly progressive liver light chain deposition under VAD chemotherapy in multiple myeloma. Eur J Haematol 76:83–85

    Article  PubMed  Google Scholar 

  • Sarsik B, Sen S, Kirdok FS, Akarca US, Toz H, Yilmaz F (2012) Hepatic amyloidosis: morphologic spectrum of histopathological changes in AA and nonAA amyloidosis. Pathol Res Pract 208:713–718

    Article  CAS  PubMed  Google Scholar 

  • Sasaki M, Nakanuma Y, Terada T, Hoso M, Saito K, Hayashi M, Kurumaya H (1990) Amyloid deposition in intrahepatic large bile ducts and peribiliary glands in systemic amyloidosis. Hepatology 12:743–746

    Article  CAS  PubMed  Google Scholar 

  • Satani T, Yokose T, Kaburagi T, Asato Y, Itabashi M, Amemiya R (2007) Amyloid deposition in primary pulmonary marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Pathol Int 57:746–750

    Article  CAS  PubMed  Google Scholar 

  • Schmid PA, Burger HR, Spycher MA, Bühler H, Heitz PU (1992) Primary amyloidosis of the liver (in German). Dtsch Med Wochenschr 117:1014–1018

    Article  CAS  PubMed  Google Scholar 

  • Shibasaki T, Matsumoto H, Watabe K, Joh K, Nakano H, Matsuda H, Gomi H, Ohno I, Ishimoto F, Sakai O (1997) A case of renal amyloidosis associated with hepatic adenoma: the pathogenetic role of tumor necrosis factor-alpha. Nephron 75:350–353

    Article  CAS  PubMed  Google Scholar 

  • Simmonds PD, Cottrell BJ, Mead GM, Wright DH, Whitehouse JM (1997) Lymphadenopathy due to amyloid deposition in non-Hodgkin’s lymphoma. Ann Oncol 8:267–270

    Article  CAS  PubMed  Google Scholar 

  • Smith NM, Malcolm AJ (1986) Simultaneous AL-type amyloid and light chain deposit disease in a liver biopsy: a case report. Histopathology 10:1057–1064

    Article  CAS  PubMed  Google Scholar 

  • Soma J, Sato K, Sakuma T, Saito H, Sato H, Sato T, Abbas A, Aucouturier P (2004) Immunoglobulin gamma3-heavy-chain deposition disease: report of a case and relationship with hypocomplementemia. Am J Kidney Dis 43:E10–E16

    Article  PubMed  Google Scholar 

  • Son RC, Chang JC, Choi JH (2011a) Primary hepatic amyloidosis: report of an unusual case presenting as a mass. Korean J Radiol 12:382–385

    Article  PubMed  PubMed Central  Google Scholar 

  • Son YM, Choi JY, Bak CH, Cheon M, Kim YE, Lee KH, Kim BT (2011b) 18F-FDG PET/CT in primary AL hepatic amyloidosis associated with multiple myeloma. Korean J Radiol 12:634–637

    Article  PubMed  PubMed Central  Google Scholar 

  • Stokes MB, Jagirdar J, Burchstin O, Kornacki S, Kumar A, Gallo G (1997) Nodular pulmonary immunoglobulin light chain deposits with coexistent amyloid and nonamyloid features in an HIV-infected patient. Mod Pathol 10:1059–1065

    CAS  PubMed  Google Scholar 

  • Szturz P, Kyclova J, Moulis M, Navratil M, Adam Z, Vanicek J, Mayer J (2013) Extensive AL amyloidosis presenting with recurrent liver hemorrhage and hemoperitoneum: case report and literature review. Klin Onkol 26:49–52

    Article  CAS  PubMed  Google Scholar 

  • Tabata S, Kurata M, Takeda J, Funayama Y, Yamauchi N, Aoki K, Kato A, Ono Y et al (2012) Fatal hepatic failure due to AL amyloidosis in a patient with multiple myeloma. Rinsho Ketsueki 53:1906–1910

    PubMed  Google Scholar 

  • Tam M, Seldin DC, Forbes BM, Connors LH, Skinner M, Oran B, Quillen K, Sanchorawala V (2009) Spontaneous rupture of the liver in a patient with systemic AL amyloidosis undergoing treatment with high-dose melphalan and autologous stem cell transplantation: a case report with literature review. Amyloid 16:103–107

    Article  PubMed  PubMed Central  Google Scholar 

  • Terada T, Hirata K, Hisada Y, Hoshii Y, Nakanuma Y (1994) Obstructive jaundice caused by the deposition of amyloid-like substances in the extrahepatic and large intrahepatic bile ducts in a patient with multiple myeloma. Histopathology 24:485–487

    Article  CAS  PubMed  Google Scholar 

  • Thysell H, Ingvar C, Gustafson T, Holmin T (1986) Systemic reactive amyloidosis caused by hepatocellular adenoma. A case report. J Hepatol 2:450–457

    Article  CAS  PubMed  Google Scholar 

  • Tötterman KJ, Manninen V (1982) Tumefactive liver infiltration in amyloidosis. Ann Clin Res 14:11–14

    PubMed  Google Scholar 

  • Toyoda M, Kajita A, Kita S, Osamura Y, Shinoda T (1988) An autopsy case of diffuse myelomatosis associated with systemic kappa light chain deposition disease (LCDD). A patho-anatomical, immunohistochemical and immunobiological study. Acta Pathol Jpn 38:479–488

    CAS  PubMed  Google Scholar 

  • Tschang TP (1976) Nodular malignant lymphoma and amyloidosis. A case report. Cancer 38:2192–2196

    Article  CAS  PubMed  Google Scholar 

  • Varela M, De Las Heras D, Miguel R (2003) Hepatic failure due to primary AL amyloidosis. J Hepatol 39:290

    Article  CAS  PubMed  Google Scholar 

  • Vidal R, Goni F, Stevens F, Aucouturier P, Kumar A, Frangione B, Ghiso J et al. (1999) Somatic mutations of the LRA gene in V-kl light chain deposition disease. Potential effects on aberrant protein conformation and deposition. Am J Pathol 155:2009–2017

    Google Scholar 

  • Wang YD, Zhao CY, Yin HZ (2012) Primary hepatic amyloidosis: a mini literature review and five cases report. Ann Hepatol 11:721–727

    PubMed  Google Scholar 

  • Weisel KC, Böckeler M, Bianchi L, Terracciano LM, Mayer F, Kanz L (2009) Development of rapid light-chain deposition disease in hepatic arteries with severe ischemic cholangitis in a multiple myeloma patient treated with melphalan, prednisone and lenalidomide. Int J Hematol 89:91–94

    Article  PubMed  Google Scholar 

  • Westermark P (2012) Localized AL amyloidosis: a suicidal neoplasm? Upsala J Med Sci 117:244–250

    Article  PubMed  PubMed Central  Google Scholar 

  • Yamamoto T, Maeda N, Kawasaki H (1995) Hepatic failure in a case of multiple myeloma-associated amyloidosis (kappa-AL). J Gastroenterol 30:393–397

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arthur Zimmermann .

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this entry

Cite this entry

Zimmermann, A. (2017). Amyloidogenic Immunoglobulin Chain and Non-amyloidogenic Immunoglobulin Chain Diseases. In: Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Springer, Cham. https://doi.org/10.1007/978-3-319-26956-6_93

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26956-6_93

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-26954-2

  • Online ISBN: 978-3-319-26956-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics